Brazil vs Oceania (exc. Australia and New Zealand): Proportion of the target population who received the final dose
Brazil
79.0%
in 2024
Oceania (exc. Australia and New Zealand)
14.0%
in 2024
Brazil rank
24th
Oceania (exc. Australia and New Zealand) rank
27th
Proportion of the target population who received the final dose over time
- Brazil
- Oceania (exc. Australia and New Zealand)
How they compare
Brazil currently reports 79.0% against 14.0% in Oceania (exc. Australia and New Zealand), a difference of 65.0%.
That makes Brazil's figure about 5.6 times Oceania (exc. Australia and New Zealand)'s.
Across all 11 years both countries report, Brazil has been ahead every year.
Brazil ranks 24th and Oceania (exc. Australia and New Zealand) ranks 27th of 108 countries.
Brazil has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Brazil | Oceania (exc. Australia and New Zealand) | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 68.7% | 4.5% | 64.2% | Brazil |
| 2020s | 73.2% | 8.4% | 64.8% | Brazil |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received the final dose of, Brazil or Oceania (exc. Australia and New Zealand)?
- Brazil, at 79.0% against 14.0% in Oceania (exc. Australia and New Zealand) as of 2024.
- What is the difference in proportion of the target population who received the final dose of between Brazil and Oceania (exc. Australia and New Zealand)?
- 65.0%, with Brazil ahead.
- How many years of comparable data are there for Brazil and Oceania (exc. Australia and New Zealand)?
- 11 years are reported by both, from 2014 to 2024.
- How do Brazil and Oceania (exc. Australia and New Zealand) rank globally for proportion of the target population who received the final dose of?
- Brazil ranks 24th and Oceania (exc. Australia and New Zealand) ranks 27th of 108 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.